Rexon-Eye® – How it works:
Rexon-Eye is the first medical device with QMR® technology applied to ophthalmology, developed specifically to treat Dry Eye Disease.
→ It acts on the regeneration of the Meibomian glands and ocular surface tissues
→ It stimulates natural biological processes, without the need for medication
→ It reduces inflammation, promoting prolonged symptom relief
QMR® – Quantum Molecular Resonance
The QMR® technology is based on the emission of alternating electrical currents, with multiple frequencies between 4 MHz and 64 MHz, capable of interacting with cells and promoting tissue regeneration and and anti-inflammatory effects, without generating heat..
QMR® technology has been successfully applied for years in other areas of medicine, such as dermatology, physiotherapy and aesthetic medicine.
Rexon-Eye® Treatment
The treatment consists of 4 weekly sessions of 20 minutes each,with the patient seated, wearing a specific eye mask.
✔ No direct contact with the eye
✔ Painless, comfortable and relaxing
✔ Suitable for all skin types and phototypes
✔ Applicable to all types of dry eye (evaporative, aqueous and mixed)
Healthcare Professional Advantages
Technical Data
Clinical Evidence
Published clinical studies show:
– Significant improvement in subjective symptoms (OSDI, quality of life questionnaires)
– Increased tear film stability (BUT, osmolarity)
– Increased tear production (Schirmer test)
– Improved meibomian gland function
– Reduction in inflammatory markers
Sustained results several months after the treatment
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved
